Esteemed Neurosurgery Professor and Spinal Surgeon Dr. Erica Bisson Joins Proprio As Research Advisor


Seattle, WA - January 11, 2022 - Proprio, the Seattle medical technology company enabling surgeons to perform complex procedures through the combination of computer vision, machine learning, and immersive technology, is pleased to announce that Dr. Erica Bisson, MD, MPH has joined as a Research Advisor.

Dr. Bisson, Professor of Neurosurgery and Adjunct Professor of Orthopaedics within the University of Utah’s Spine Division in their Department of Neurosurgery, specializes in complex spinal surgeries, and has an extensive background in treating degenerative spinal conditions, spine trauma, and spine injuries.

“We’re honored to have Dr. Bisson join us as an integral research advisor to our team,” Gabriel Jones, CEO and Co-founder of Proprio emphasized. “As we leverage technology breakthroughs to deliver the new way of seeing for surgery, insight and expertise like Dr. Bisson’s is essential. We’re thrilled to welcome Dr. Bisson to our world-class team, and look forward to ongoing collaboration with her to create opportunities for unprecedented advancements in the medical industry.”

“I look forward to advising Proprio on the development of their technology and discussing how it can positively impact the surgical suite of today,” noted Dr. Bisson. “Proprio has an opportunity to improve both surgeon and patient outcomes by blending new technologies with surgical expertise, and I am eager to take part in this exciting endeavor.”

About Dr. Erica Bisson
Dr. Erica Bisson is Professor of Neurosurgery, as well as Adjunct Professor of Orthopaedics, at the University of Utah. She received her medical school training at Tufts University School of Medicine and her Neurosurgical training at the University of Vermont. She then went on to complete a fellowship in complex spinal disorders at the University of Utah, under the direction of Dr. Ronald Apfelbaum. She joined the Spine Division in the Department of Neurosurgery at the University of Utah in 2009. Within the department, she serves as the Director of the CAST approved Neurosurgical Spine Fellowship and as the Vice Chair for Diversity and Inclusion.

Dr. Bisson is a fellow of the American Board of Neurological Surgeons, and a member of the American Association of Neurological Surgeons, Spine Section. She has published over 100 peer-reviewed articles and serves as principal investigator on several national and international multicenter trials. She continues to work collaboratively on research with faculty in Neuroradiology and Exercise and Sports Medicine at the University of Utah as well as Neurosurgery Spine faculty at the Medical College of Wisconsin. Additionally, she serves in many leadership roles in national neurosurgical organizations, including being a member of the Editorial Board for the Journal of Neurosurgery and serving as the Scientific Program Chair for the AANS/CNS Joint Section on Spine and Peripheral Nerves. Most recently, Dr. Bisson was also elected to a 2 year term as the President of the University of Utah Medical Board.

Dr. Bisson specializes in complex spine surgery with a focus on cervical disease (neck pain), utilizing both novel artificial disc and fusion technology. She also treats patients with spinal cord injury, spine trauma, and degenerative spinal conditions (neck and back pain). Dr. Bisson’s professional interests include occipitocervical disease, cervical degenerative disorders, advanced spinal fusion techniques, and image-guided surgery.

About Proprio
Proprio is a medical technology company based in Seattle, Washington. We create the new way of seeing™ in surgery through a proprietary platform that synthesizes artificial intelligence, computer vision, augmented/virtual reality, and robotics. Proprio’s goal is to dramatically improve clinical and economic outcomes through the combination of physician expertise and immersive, intelligent technology. Proprio is backed by leading healthcare and technology investors, including DCVC (Data Collective), BOLD Capital Partners, Cota Capital, Intel, HTC, and Alan Frazier, founder of Frazier Healthcare Partners. For more information, visit